Argonautica Private Wealth Management, Inc Regeneron Pharmaceuticals, Inc. Transaction History
Argonautica Private Wealth Management, Inc
- $302 Billion
- Q3 2024
A detailed history of Argonautica Private Wealth Management, Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Argonautica Private Wealth Management, Inc holds 468 shares of REGN stock, worth $385,856. This represents 0.16% of its overall portfolio holdings.
Number of Shares
468
Previous 466
0.43%
Holding current value
$385,856
Previous $490 Million
0.45%
% of portfolio
0.16%
Previous 0.17%
Shares
3 transactions
Others Institutions Holding REGN
# of Institutions
1,490Shares Held
85.8MCall Options Held
908KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$7.42 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.96 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$6.82 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$3.99 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$3.82 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $88.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...